These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 11655169)
21. Why we need a national human experimentation agency. Annas GJ Account Res; 1999; 7(2-4):293-302. PubMed ID: 11658184 [No Abstract] [Full Text] [Related]
22. Ethics lapses at Duke halt dozens of human experiments. Hilts PJ; Stolberg SG N Y Times Web; 1999 May; ():A26. PubMed ID: 11648115 [No Abstract] [Full Text] [Related]
23. An overview of FDA, IRBs and regulations. Petricciani JC IRB; 1981 Dec; 3(10):1-3, 11. PubMed ID: 11649413 [No Abstract] [Full Text] [Related]
24. In tests on people, who watches the watchers? Hilts PJ N Y Times Web; 1999 May; ():F1, F4. PubMed ID: 11648129 [No Abstract] [Full Text] [Related]
25. Emergency medicine and the development of the Food and Drug Administration's final rule on informed consent and waiver of informed consent in emergency research circumstances. Biros MH; Runge JW; Lewis RJ; Doherty C Acad Emerg Med; 1998 Apr; 5(4):359-68. PubMed ID: 9562204 [TBL] [Abstract][Full Text] [Related]
26. Federal agency's final rule says informed consent forms must be dated. Maloney DM Hum Res Rep; 1996 Dec; 11(12):1-2. PubMed ID: 11655034 [No Abstract] [Full Text] [Related]
27. Two rules on expedited IRB reviews are final. Maloney DM Hum Res Rep; 1999 Jan; 14(1):3. PubMed ID: 11657557 [No Abstract] [Full Text] [Related]
28. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns. Kobasic DM J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168 [No Abstract] [Full Text] [Related]
29. IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury. Prentice ED; Antonson DL; Leibrock LG; Kelso TK; Sears TD IRB; 1993; 15(5):1-7. PubMed ID: 11659703 [No Abstract] [Full Text] [Related]
30. Court tells jury to ignore human subject protection regulations. Maloney DM Hum Res Rep; 1995 Mar; 10(3):4-5. PubMed ID: 11654195 [No Abstract] [Full Text] [Related]
31. An IRB member's perspective on access to innovative therapy. Moore DL Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854 [No Abstract] [Full Text] [Related]
32. Testing drugs in pediatric populations: the FDA mandate. Tauer CA Account Res; 1999; 7(1):37-58. PubMed ID: 11657562 [No Abstract] [Full Text] [Related]
33. The impact of institutional review boards on clinical research. Levine RJ Perspect Biol Med; 1980 Pt 2): S99-S114, Winter; 23(2):. PubMed ID: 11663073 [No Abstract] [Full Text] [Related]
34. All is not well in research on human subjects. Goldman J N Y Times Web; 1986 Mar; ():A26. PubMed ID: 11647822 [No Abstract] [Full Text] [Related]
36. Considering experimentation and elusive truth: informed consent made difficult. Brodeur D Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444 [No Abstract] [Full Text] [Related]
37. Regulation of clinical research: who's protecting who from what? Petricciani JC Food Drug Cosmet Law J; 1979 Apr; 34(4):205-7. PubMed ID: 11661718 [No Abstract] [Full Text] [Related]
38. Ethics in neurobiological research with human subjects -- final reflections. Katz J Account Res; 1996; 4(3-4):277-83. PubMed ID: 11654523 [No Abstract] [Full Text] [Related]
39. Government regulation of scientific research. Robertson JA Jurimetrics; 1979; 19(4):301-38. PubMed ID: 11651670 [No Abstract] [Full Text] [Related]
40. Informed consent: the FDA's perspective. Bagley G Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]